The Discounted Cash Flow (DCF) valuation of Sprint Bioscience AB (SPRINT.ST) is 2.10 SEK. With the latest stock price at 1.57 SEK, the upside of Sprint Bioscience AB based on DCF is 33.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.0% - 8.6% | 6.8% |
| Long-term Growth Rate | 2.5% - 4.5% | 3.5% |
| Fair Price | 1.37 - 10.64 | 2.10 |
| Upside | -12.8% - 579.6% | 33.9% |